FGF7 and ovarian cancer: Comparison of patient groups with serum FGF7 levels above the median versus below the median demonstrated significant association of higher serum FGF7 protein levels with worse PFS for patients with ovarian cancer (Log-rank test p = 0.005, Figure 5D) and also with OS (Log-rank test p = 0.019, Figure 5E).